Evolutionary Genomics, Inc. financial data

Symbol
FNAM on OTC
Location
4220 Morningstar Drive, Castle Rock, CO
State of incorporation
Nevada
Fiscal year end
December 31
Former names
Fona, Inc. (to 10/21/2015)
Latest financial report
10-K - Q4 2022 - Mar 9, 2023

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 929 % +48.1%
Debt-to-equity -77.4 % +16.7%
Return On Equity 38.9 % -53.9%
Return On Assets -66.5 % +20.6%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 6.66M shares +0.61%
Common Stock, Shares, Outstanding 6.66M shares +13.1%
Entity Public Float 3.14M USD -32.3%
Common Stock, Value, Issued 6.66K USD +13.1%
Weighted Average Number of Shares Outstanding, Basic 6.46M shares +9.81%
Weighted Average Number of Shares Outstanding, Diluted 6.46M shares +9.81%

Income Statement

Label TTM Value / Value Unit Change %
Research and Development Expense 417K USD -66.2%
General and Administrative Expense 1.25M USD -1.58%
Operating Income (Loss) -2.01M USD +30%
Nonoperating Income (Expense) 79.3K USD -5.55%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest -1.93M USD +30.7%
Net Income (Loss) Attributable to Parent -1.93M USD +30.7%
Earnings Per Share, Basic -0.35 USD/shares +32.7%
Earnings Per Share, Diluted -0.35 USD/shares +32.7%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 577K USD +170%
Assets, Current 699K USD +173%
Property, Plant and Equipment, Net 3.96K USD -78.8%
Assets 2.35M USD -19.7%
Liabilities, Current 159K USD +300%
Liabilities 3.92M USD +4.24%
Retained Earnings (Accumulated Deficit) -19.8M USD -10.8%
Stockholders' Equity Attributable to Parent -5.59M USD -27.1%
Liabilities and Equity 2.35M USD -19.7%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -176K USD +9.73%
Net Cash Provided by (Used in) Financing Activities 1M USD +1214%
Net Cash Provided by (Used in) Investing Activities 0 USD
Common Stock, Shares Authorized 780M shares 0%
Common Stock, Shares, Issued 6.66M shares +13.1%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 577K USD +170%
Deferred Tax Assets, Valuation Allowance 3.19M USD +12.4%
Depreciation 14.7K USD -54%
Property, Plant and Equipment, Gross 504K USD 0%
Deferred Tax Assets, Operating Loss Carryforwards 2.93M USD +1.8%
Preferred Stock, Shares Authorized 20M shares 0%
Depreciation, Depletion and Amortization 255K USD -1.67%
Deferred Tax Assets, Net of Valuation Allowance 309K USD -52.6%
Share-based Payment Arrangement, Expense 78.2K USD +42.3%
Preferred Stock, Par or Stated Value Per Share 0 USD/shares 0%